BC
ONCT

BIT Capital’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

BIT Capital’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,500
Closed -$44.3K – 192
2022
Q3 		$44.3K Hold
2,500
– – 0.01% 136
2022
Q2 		$54.3K Buy
+2,500
New +$55.7K 0.01% 107

Other funds holding ONCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $324M AUM 37.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

BIT Capital's ONCT Position: Q2 2023 in Review

BIT Capital sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q2 2023, closing a stake of 36,673 shares — an estimated $566K sold.

BIT Capital first reported a position in ONCT in Q2 2022 and held it in 4 quarters. The position peaked at $566K in Q1 2023. 52 funds tracked by Wall St. Rank hold ONCT as of Q2 2023.

  • BIT Capital reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • BIT Capital sold 36,673 Oncternal Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $566K.
  • BIT Capital first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • BIT Capital's Oncternal Therapeutics, Inc. Common Stock position peaked at $566K in Q1 2023.
  • 52 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q2 2023.

Based on BIT Capital's 13F filing for Q2 2023, filed 12 Feb 2025.